首页|右美托咪定联合无创正压通气在慢阻肺中的应用及对血流动力学的影响

右美托咪定联合无创正压通气在慢阻肺中的应用及对血流动力学的影响

扫码查看
目的:探讨右美托咪定联合无创正压通气在慢阻肺中的应用及对血流动力学的影响.方法:选择 2021 年 1 月—2022 年 1 月在漳州正兴医院接受治疗的 73 例慢阻肺患者,采用随机数表法分为试验组(n=37)和对照组(n=36).对照组给予无创正压通气治疗,试验组在对照组基础上加用右美托咪定治疗.比较两组临床疗效、心率、平均动脉压、动脉血二氧化碳分压(PaCO2)、动脉血氧分压(PaO2)、pH值及不良反应发生情况.结果:试验组总有效率为 91.89%,对照组为 72.22%,两组比较,差异有统计学意义(P<0.05);治疗后,试验组心率、平均动脉压均低于对照组,差异均有统计学意义(P<0.05);治疗后,两组PaO2、pH值均显著升高,试验组均高于对照组,PaCO2 均显著降低,试验组低于对照组,差异均有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:慢阻肺患者应用右美托咪定联合无创正压通气治疗有较好的效果,可有效改善血流动力学,安全性高.
Application of Dexmedetomidine Combined with Non-invasive Positive Pressure Ventilation in COPD and Its Influence on Hemodynamics
Objective:To investigate the application of Dexmedetomidine combined with non-invasive positive pressure ventilation in chronic obstructive pulmonary diseases and its influence on hemodynamics.Method:A total of 73 patients with chronic obstructive pulmonary diseases treated in Zhangzhou Zhengxing Hospital from January 2021 to January 2022 were selected and divided into experimental group(n=37)and control group(n=36)according to random number table method.The control group was treated with non-invasive positive pressure ventilation,and the experimental group was treated with Dexmedetomidine on the basis of control group.The clinical efficacy,heart rate,mean arterial pressure,arterial partial pressure of carbon dioxide(PaCO2),arterial partial pressure of oxygen(PaO2),pH value and the occurrence of adverse reactions were compared between the two groups.Result:The total effective rate was 91.89%in experimental group and 72.22%in control group,the difference between the two groups was statistically significant(P<0.05).After treatment,the heart rate and mean arterial pressure of experimental group were lower than those of control group,the differences were statistically significant(P<0.05).After treatment,PaO2 and pH values of both groups were significantly increased,and those in the experimental group were higher than those in the control group,PaCO2 of both groups were significantly decreased,and that in the experimental group was lower than that in the control group,the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Dexmedetomidine combined with non-invasive positive pressure ventilation has a good effect on patients with chronic obstructive pulmonary diseases,which can effectively improve hemodynamics and has high safety.

DexmedetomidineNon-invasive positive pressure ventilationChronic obstructive pulmonary diseasesHemodynamics

王海华、许鸿东

展开 >

漳州正兴医院呼吸与危重症医学科 福建 漳州 363000

右美托咪定 无创正压通气 慢阻肺 血流动力学

2024

中国医学创新
中国保健协会

中国医学创新

影响因子:1.706
ISSN:1674-4985
年,卷(期):2024.21(2)
  • 17